Upper extremity lymphedema after treatment for breast cancer: A review of the literature

Ostomy Wound Management

Volumn 53, Issue 5, 2007, Pages

  Meneses, Karen Dow ^a   McNees, M Patrick ^b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b NONE

Author keywords

Breast cancer; Review; Upper extremity lymphedema

Indexed keywords

ANTHROPOMETRY; ARM; BREAST TUMOR; CLINICAL PROTOCOL; COMPRESSION STOCKING; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; LYMPHADENECTOMY; LYMPHEDEMA; MASTECTOMY; NEEDS ASSESSMENT; NURSING ASSESSMENT; PATIENT EDUCATION; PRIMARY PREVENTION; QUALITY CONTROL; QUALITY OF LIFE; RADIOTHERAPY; REVIEW; RISK ASSESSMENT; SURVIVOR;

ANTHROPOMETRY; BENCHMARKING; BREAST NEOPLASMS; CLINICAL PROTOCOLS; EVIDENCE-BASED MEDICINE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY; NEEDS ASSESSMENT; NURSING ASSESSMENT; PATIENT EDUCATION; PRIMARY PREVENTION; QUALITY OF LIFE; RADIOTHERAPY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STOCKINGS, COMPRESSION; SURVIVORS; UPPER EXTREMITY;

EID: 34250373660     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology. 2003;36(2):84-91.
2. Dharmananda S. Chinese herbs for lymphedema: exploring the principles of treating phlegm-damp accumulation. Available at: http://www.itmonline.org/arts/ lymphedema.htm. Accessed July 20, 2006.
3. Meige H. Dystrophie oedematose hereditaire. La Presse Medical. 1989;6:341-343.
4. Milroy W. An undescribed variety of hereditary edema. NY Medical Journal. 1892;56:505508.
5. Nonne M. Vier Falle von elephantiasis congenita hereditaria (Virchows). Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin. 1891:189-196.
6. King MJ, DiFalco EG. Lymphedema: skin and wound care in an aging population. Ostomy Wound Manage. 2005;51(11 suppl A):14-1 6.
7. Cancer survivorship statistics.
8. Available at: http://cancercontrol.cancer/gov/ocs/index.html. Accessed July 20, 2006.
9. Institute of Medicine. From cancer patient to cancer survivor: Lost in transition. 2006. National Academy of Sciences: Washington, DC.
10. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003;79(1):47-57.
11. Geller BM, Vacek PM, O'Brien P, Seeker-Walker RH. Factors associated with arm swelling after breast cancer surgery. J Womens Health (Larchmt). 2003;12(9):921-930.
12. Mathew J, Barthelmes L, Neminathan S, Crawford D. Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery. Eur J Surg Oncol. 2006;32(7):729-732.
13. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92(6):1368-1377.
14. Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin. 2000;50(5):292-307.
15. Van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R. Lymphedema development following breast cancer surgery with full axillary resection. Lymphology. 2004;37(4):206-208.
16. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37(8):991-999.16. American Cancer Society. Lymphedema: understanding and managing lymphedema after cancer treatment. American Cancer Society;2006.
17. Bosompra K, Ashikaga T, O'Brien PJ, Nelson L, Skelly J. Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: a disablement process model perspective. Breast J. 2002;8(6):338-348.
18. Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20(20):4242-4248.
19. Morgan PA, Franks PJ, Moffatt CJ. Health-related quality of life with lymphoedema: a review of the literature. Int Wound J. 2005;2(1):47-62.
20. Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005; 13(11):904-911.
21. Temple K, Baron R, Cody H, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002;9(7):654-662.
22. Armer J. Lymphedema. In: Dow KH, ed. Contemporary Issues in Breast Cancer, 2nd ed. Sudbury, Mass: Jones and Bartlett;2004.
23. Armer J. Lymphedema. In: Dow KH, ed. Nursing Care of Women with Cancer. Philadelphia, Pa: Elsevier;2006.
24. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37(2):73-91.
25. Carter BJ. Women's experiences of lymphedema. Oncol Nurs Forum. 1997;24(5):875-882.
26. Coward D. Lymphedema prevention and management knowledge in women treated for breast cancer. Oncol Nurs Forum. 1999;26(6):1047-1053.
27. Moffatt CJ, Franks P, Doherty DC, et al. Lymphoedema: an underestimated health problem. QJM. 2003;96(10):731-738.
28. Hare M. The lived experience of breast cancer related lymphoedema. Nurs Stand. 2000;15(7):35-39.
29. Johansson K, Holmstrom H, Nilsson I, Ingvar C, Albertsson M, Ekdahl C. Breast cancer patients' experiences of lymphoedema. Scand J Caring Sci. 2003;17(1):35-42.
30. Paskett E, Stark N. Lymphedema: knowledge, treatment and impact among breast cancer survivors. Breast J. 2000;6(6):373-378.
31. Passik SD, McDonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer. 1998;83(12 suppl American):281 7-2820.
32. Williams AF, Moffatt CJ, Franks PJ. A phenomenological study of the lived experiences of people with lymphoedema. Int J Palliat Nurs. 2004; 10(6):279-286.
33. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clin Proc. 2005;80(11):1480-1484.
34. Mortimer PS. The pathophysiology of lymphedema. Cancer. 1998;83(12 suppl American):2798-2802.
35. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98(5):343-348.
36. Coen J, Taghian A, Kachnic L, Assaad S, Powell S. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Intl J Radiat Oncol Biol Phys. 2003;55(5):1209-1215.
37. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93(2):96-111.
38. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004; 10(5):405-411.
39. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer. 2001;92(7):1783-1787.
40. Hinrichs CS, Watroba NL, Rezaishiraz H, et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol. 2004;11(6):573-580.
41. Kosir MA, Rymal C, Koppolu P, et al. Surgical outcomes after breast cancer surgery: measuring acute lymphedema. J Surg Res. 2001;95(2):147-151.
42. Meek AG. Breast radiotherapy and lymphedema. Cancer. 1998;83(12 suppl American):2788-2797.
43. Pain S, Vowler S, Purushotham A. Axillary vein abnormalities contribute to development of lymphoedema after surgery for breast cancer. Br J Surg. 2005;92(3):311-315.
44. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Taylor ME, Thiadens SR. Lymphedema management. Semin Radiat Oncol. 2003;13(3):290-301.
45. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599-609.
46. Pater J, Parulekar W. Sentinel lymph node biopsy in early breast cancer: has its time come? J Natl Cancer Inst. 2006;98(9):568-569.
47. Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23(19):4312-4321.
48. Ronka R, von Smitten K, Tasmuth T, Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast. 2005;14(1):28-36.
49. Schijven MP, Vingerhoets AJ, Rutten HJ. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol. 2003;29(4):341-350.
50. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol. 2006;93(2):109-119.
51. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92(4):748-752.
52. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13(4):491-500.
53. Loerzel V, Dow KH, McNees P. Why women with breast cancer use or don't use lymphedema prevention and management strategies. Conference Proceedings of the American Psychosocial Oncology Society 3rd Annual Conference. Amelia Island, Fla;2006.
54. Loerzel V, Dow KH, McNees, P. Incidental findings related to lymphedema incidence and prevention in quality of life research. Qual Life Res. 2005;14 (9):2039
55. Muscari E. Lymphedema: responding to our patients' needs. Oncol Nurs Forum. 2004;31(5):905-912.
56. Armer J, Fu MR. Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nurs. 2005;28(3):200-207.
57. NCI common toxicity criteria for adverse events (CTCAE) v3 grading. Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed December 8, 2006.
58. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003; 13(3):214-225.
59. Armer JM. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005;23(1):76-83.
60. Damstra RJ, Glazenburg EJ, Hop WC. Validation of the inverse water volumetry method: a new gold standard for arm volume measurements. Breast Cancer Res Treat. 2006;99(3):267-273.
61. Hayes S, Cornish B, Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6 month follow up. Breast Cancer Res Treat. 2005;89(3):221-226.
62. Megens AM, Harris SR, Kim-Sing C, McKenzie DC. Measurement of upper extremity volume in women after axillary dissection for breast cancer. Arch Phys Med Rehabil. 2001;82(12):1639-1644.
63. Mellor RH, Bush NL, Stanton AW, Bamber JC, Levick JR, Mortimer PS. Dual-frequency ultrasound examination of skin and subcutis thickness in breast cancer-related lymphedema. Breast J. 2004;10(6):496-503.
64. Ramos SM, O'Donnell LS, Knight G. Edema volume, not timing, is the key to success in lymphedema treatment. Am J Surg. 1999;178(4):311-315.
65. Sander AP, Hajer NM, Hemenway K, Miller AC. Upperextremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther. 2002;82(12):1201-1212.
66. Taylor R, Jayasinghe UW, Koelmeyer L, Ung O, Boyages J. Reliability and validity of arm
67. volume measurements for assessment of lymphedema. PhysTher. 2006;86(2):205-214.
68. Tierney S, Aslam M, Rennie K, Grace P. Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vase Endovasc Surg. 1996;12(4):412-417.
69. Badger C, Preston N, Seers K, Mortimer P. Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev. 2004.
70. Cohen SR, Payne DK, Tunkel RS. Lymphedema: strategies for management. Cancer. 2001;92(4 suppl):S980-S987.
71. Farinola N, Piller N. Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema. Lymphat Res Biol. 2005;3(2):81-86.
72. Forchuk C, Baruth P, Prendergast M, et al. Postoperative arm massage: a support for women with lymph node dissection. Cancer Nurs. 2004;27(1):25-33.
73. Kligman L, Wong RK, Johnston M, Laetsch NS. The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Support Care Cancer. 2004;12(6):421-431.
74. Loprinzi CL, Kugler JW, Sloan JA, et al. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999;340(5):346-350.
75. McNeely ML, Magee DJ, Lees AW, Bagnall KM, Haykowsky M, Hanson J. The addition of manual lymph drainage to compression therapy for breast cancer-related lymphedema: a randomized controlled trial. Breast Cancer Res Treat. 2004;86(2):95-106.
76. Mondry TE, Riffenburgh RH, Johnstone PA. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J. 2004;10(1):42-48; discussion 17-49.
77. Piller NB, Thelander A. Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology. 1998;31(2):74-86.
78. Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer. 2002;95(11):2260-2267.
79. Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl). 2002;11(4):254-261.
80. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol. 2006;24(18):2765-2772.
81. Johansson K, Tibe K, Weibull A, Newton RC. Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005;38(4):167-180.
82. Vignes S, Porcher R, Arrault M, Dupuy A. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat. 2007;101(3):285-290.
83. Franks PJ, McCullagh L, Moffatt CJ. Assessing quality of life in patients with chronic leg ulceration using the Medical Outcomes Short Form-36 questionnaire. Ostomy Wound Manage. 2003;49(2):26-37.
84. Franks PJ, Moffatt CJ, Doherty DC, Williams AF, Jeffs E, Mortimer PS. Assessment of health-related quality of life in patients with lymphedema of the lower limb. Wound Repair Regen. 2006;14(2):110-118.
85. Runowicz C, Passik S, Hahn D, Berson A, Chang H, K M. Workgroup II Patient education pre and post treatment. Cancer Suppl. 1998:2880-2881.
86. National Lymphedema Network. Lymphedema: a brief overview. Available at: http://
87. www.lymphnet.org. Accessed December 8, 2006.
88. Lymphology Association of North America. Available at: http://www.clt-lana.org. Accessed December 8, 2006.